Craniofacial Bone Tissue Engineering is a cutting-edge field dedicated to developing innovative strategies for the regeneration and repair of bone structures in the craniofacial region. This area encompasses the bones of the skull, face, and jaw, which are vital for functions such as protection, support, and aesthetics. The field leverages principles from materials science, biology, and engineering to create scaffolds and biomimetic constructs that mimic the natural architecture of craniofacial bones. These constructs are often integrated with bioactive factors and cells to promote tissue regeneration. Researchers focus on identifying suitable cell sources, such as mesenchymal stem cells, and optimizing biomaterials to create scaffolds that provide mechanical support and encourage cell adhesion, proliferation, and differentiation. Techniques like 3D printing and bioprinting further enhance the precision and complexity of these constructs. Craniofacial bone tissue engineering aims to address challenges associated with trauma, congenital deformities, or surgical interventions that result in bone loss or damage. Successful craniofacial bone tissue engineering holds promise for personalized treatments, reducing the need for autografts or allografts and minimizing complications associated with traditional bone grafting methods. Ongoing research in this field contributes to advancements in regenerative medicine, with the potential to transform the landscape of craniofacial reconstruction, oral surgery, and orthopedics. In summary, craniofacial bone tissue engineering is a multidisciplinary pursuit aiming to develop effective and personalized solutions for the regeneration and reconstruction of bones in the craniofacial region, offering innovative alternatives to conventional approaches.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy